Your position:m.limatoxi.com>>EN>>EN>>Pharmaceutical News>>Jiangxi Tianxin Pharmaceutical's revenue in the first half of 2024 was 1.067 billion yuan, and calcium pantothenate products achieved mass production.>> article
Jiangxi Tianxin Pharmaceutical's revenue in the first half of 2024 was 1.067 billion yuan, and calcium pantothenate products achieved mass production.
Editor:xuezhe Clicks:0Date:2024/9/5 15:24:31
Keyword:calcium pantothenate
Healthoo Information:
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • Some domestic manufacturers raise the price of calcium pantothenate.
  • Calcium pantothenate (feed) quoted prices of main producers
  • Calcium pantothenate (feed) quoted prices of main producers
  • Calcium pantothenate (feed) quoted prices of main producers
  • Calcium pantothenate (feed) quoted prices of main producers
  • Atorvastatin Calcium reference price
  • Rosuvastatin Calcium reference export price
  • Calcium pantothenate (feed) quoted prices of main producers
  • Xinfa pharmaceutical "D- calcium pantothenate" products successfully e...
  • Calcium pantothenate (feed) quoted prices of main producers
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map